Oscotec Inc. (KOSDAQ:039200)
South Korea · Delayed Price · Currency is KRW 53,000
+600 (1.15%)
Apr 10, 2026, 3:30 PM KST
Oscotec Revenue
In the year 2025, Oscotec had annual revenue of 99.84B KRW with 193.58% growth. Oscotec had revenue of 78.94B in the quarter ending December 31, 2025, with 3,279.27% growth.
Revenue
99.84B
Revenue Growth
+193.58%
P/S Ratio
20.08
Revenue / Employee
1.88B
Employees
53
Market Cap
2.00T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 99.84B | 65.83B | 193.58% |
| Dec 31, 2024 | 34.01B | 29.06B | 586.89% |
| Dec 31, 2023 | 4.95B | -111.45M | -2.20% |
| Dec 31, 2022 | 5.06B | 1.16B | 29.71% |
| Dec 31, 2021 | 3.90B | -39.57B | -91.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.56T |
| Celltrion | 4.16T |
| Samsung Epis Holdings | 3.02T |
| GC Biopharma | 1.99T |
| Daewoong Pharmaceutical | 1.57T |
| Chabiotech | 1.27T |
| ALTEOGEN | 215.86B |
| Sphere | 95.64B |